Nano-X Imaging Ltd. (NNOX) has been on a downward spiral lately with significant selling pressure. After declining 19.8% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier. Here is How to Spot Oversold Stocks We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether ...

Shares of Nano-X Imaging Ltd. (NNOX) have been struggling lately and have lost 6.8% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road. The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish cas ...

Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service New AI capabilities available to patients who submit chest and abdominal CT scans for second opinions Offering the power of Artificial Intelligence to their second opinion CT report to promote early detection of chronic conditions PETACH TIKVA, Israel, June 05, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (("Nanox" or the "Company, NASDAQ:NNOX), an innovative medical imaging technology company, today announced that i ...

Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service New AI capabilities available to patients who submit chest and abdominal CT scans for second opinions Offering the power of Artificial Intelligence to their second opinion CT report to promote early detection of chronic conditions PETACH TIKVA, Israel, June 05, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (("Nanox" or the "Company, NASDAQ:NNOX), an innovative medical imaging technology company, today announced that i ...

Nvidia is holding the stock, but that doesn't necessarily make it a terrific investment for everyday investors. Shares of Nano-X Imaging (NNOX -1.18%) are down about 53% over the past 12 months, and it's not hard to understand why. The company generated a lot of buzz when it earned Food and Drug Administration (FDA) clearance to market the Nanox.ARC a little over a year ago, but sales haven't grown. Nanox.ARC's U.S. launch isn't proceeding as quickly as investors had hoped, but some investors were encourage ...

Nano-X Imaging Ltd. (NASDAQ:NNOX) Q1 2024 Earnings Conference Call May 28, 2024 8:30 AM ET Company Participants Mike Cavanaugh - Investor Relations Erez Meltzer - Chief Executive Officer Ran Daniel - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Jeff Cohen - Ladenburg Thalmann Operator Good day and thank you for standing by. Welcome to the Nanox First Quarter 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's pres ...

Company earns Gold Seal of Approval® for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (("Nanox" or the "Company, NASDAQ:NNOX), an innovative medical imaging technology company, today announced that its wholly-owned subsidiary, USARAD Holdings, Inc., a leading provider of teleradiology services, has earned The Joint Commission's Gold Seal of Approval® for Ambulatory Health Care Accreditation for the sixth time by demonstrating continuous compl ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b ) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1 ...

财务数据和关键指标变化 - 公司在第四季度报告了GAAP净亏损1020万美元,较上年同期的5280万美元大幅下降,主要是由于上年同期计提了3650万美元的商誉减值和800万美元的集体诉讼和解费用 [33] - 第四季度收入为240万美元,毛亏为170万美元,而上年同期收入为210万美元,毛亏为180万美元 [34] - 非GAAP毛利为90万美元,毛利率约为36%,上年同期为80万美元,毛利率约为39% [34] 各条业务线数据和关键指标变化 - 远程放射诊断服务收入为230万美元,毛利为30万美元,毛利率约为14%,上年同期收入为210万美元,毛利为30万美元,毛利率约为13% [35] - 非GAAP毛利为90万美元,毛利率约为38%,上年同期为80万美元,毛利率约为40% [36] - AI解决方案收入为8.4万美元,较上年同期的6.3万美元增长 [37] 各个市场数据和关键指标变化 - 在美国,公司已在5个州部署了ARC系统,并开始为患者提供扫描服务 [10][11] - 在非洲,公司已在加纳部署了1台ARC系统,并签署了多点试验协议 [14] - 在拉丁美国,公司与秘鲁和墨西哥的分销商达成协议,开始销售Connect产品 [15][16] 公司战略和发展方向及行业竞争 - 公司正在加快在美国的商业化部署,并计划逐步增加ARC系统的部署 [9] - 公司正在扩大美国销售和技术团队,并与新的服务提供商合作以扩大服务覆盖范围 [12] - 公司正在推进ARC系统在欧洲的CE认证,并与政府机构合作探索ARC技术在安全应用中的潜力 [29][30][31] - 公司正在与Varex合作开发OEM管球,并与一家工业成像设备制造商签订了首笔生产订单 [26][27] 管理层对经营环境和未来前景的评论 - 公司在2023年取得了重要里程碑,包括ARC系统获FDA批准,这是对公司技术和使命的认可 [8] - 公司正在积极推进商业化,并期望2024年将是公司的转型之年 [9] - 公司的AI解决方案已获得FDA批准,并在临床试验中展现出良好的性能,为公司带来新的增长点 [22][23][24] 问答环节重要的提问和回答 问题1 **Ross Osborn 提问** 询问ARC系统在美国的部署情况,包括已部署的数量和2024年的部署计划 [54][55][56][57] **Erez Meltzer 和 Ran Daniel 回答** 公司已在5个州部署了ARC系统,但具体数量暂未披露。公司已制造了几十台系统,正在逐步部署和商业化 [55][56][57] 问题2 **Jeff Cohen 提问** 询问Connect产品与ARC系统的关系,以及在不同市场的商业模式 [67][70][71] **Erez Meltzer 回答** Connect产品主要销往海外市场,与ARC系统形成互补。公司采取灵活的商业模式,包括MSaaS和资本销售 [70][71][72][73] 问题3 **Anthony Petrone 提问** 询问ARC系统的使用情况,包括每天扫描量和每次扫描费用,以及AI解决方案在Intermountain Health的应用情况 [85][86][87][88][89][90][91][92] **Erez Meltzer 回答** ARC系统平均每天7次扫描,每次扫描费用30美元。公司正在拓展更多临床适应症。AI解决方案在Intermountain Health等医疗机构应用中发现了大量未被诊断的患者 [86][87][88][89][90][91][92]

Exhibit 99.1 Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update Nanox Launches Nanox.ARC in United States with Installations Across Five States, Marking a Major Advancement in Medical Imaging Management to host conference call and webcast Monday, April 1, 2024 at 8:30 AM ET PETAH TIKVA, Israel— April 1, 2024 — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the fourth quarter ended ...